Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001718860 | SCV000514088 | benign | not provided | 2018-10-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002314156 | SCV000848983 | likely benign | Inborn genetic diseases | 2014-11-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000889181 | SCV001032846 | benign | Pyruvate dehydrogenase E1-alpha deficiency | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001718860 | SCV005209132 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001833520 | SCV002076932 | likely benign | Pyruvate dehydrogenase complex deficiency | 2020-10-30 | no assertion criteria provided | clinical testing |